Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001140361-18-032512
Filing Date
2018-07-16
Accepted
2018-07-16 14:02:34
Documents
1
Effectiveness Date
2018-07-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10941
  Complete submission text file 0001140361-18-032512.txt   11998
Mailing Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110
Business Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 857-284-8891
Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)

EIN.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-316941 | Film No.: 18954220